Paper39398396
The Neuropeptide Substance P is Elevated in Sickle Cell Disease and is a Marker of Severity of Vaso-occlusive Crisis.
Olawuyi OA and 5 others. Niger Med J, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. The Neuropeptide Substance P is Elevated in Sickle Cell Disease and is a Marker of Severity of Vaso-occlusive Crisis. Papers, record 39398396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39398396
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Neuropeptide Substance P is Elevated in Sickle Cell Disease and is a Marker of Severity of Vaso-occlusive Crisis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9787150 | Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. | Blood | 1998 | https://conductscience.org/library/papers/9787150 | PubMed |
| 2 | 23608554 | Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition. | Eur Cytokine Netw | 2013 | https://conductscience.org/library/papers/23608554 | PubMed |
| 3 | 7687633 | Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling. | J Immunol | 1993 | https://conductscience.org/library/papers/7687633 | PubMed |
| 4 | 17910044 | Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management. | Am J Hematol | 2008 | https://conductscience.org/library/papers/17910044 | PubMed |
| 5 | 2457950 | Effect of neuropeptides on production of inflammatory cytokines by human monocytes. | Science | 1988 | https://conductscience.org/library/papers/2457950 | PubMed |
| 6 | 7692556 | Further evidence that substance P is a mediator of both neurogenic inflammation and pain: two phenomena inhibited either by postsynaptic blockade of NK1 receptors or by presynaptic action of opioid receptor agonists. | Regul Pept | 1993 | https://conductscience.org/library/papers/7692556 | PubMed |
| 7 | 7514197 | Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. | J Allergy Clin Immunol | 1994 | https://conductscience.org/library/papers/7514197 | PubMed |
| 8 | 9855244 | Elevated IL-8 levels during sickle cell crisis. | Eur J Haematol | 1998 | https://conductscience.org/library/papers/9855244 | PubMed |
| 9 | 23775718 | Mast cell activation contributes to sickle cell pathobiology and pain in mice. | Blood | 2013 | https://conductscience.org/library/papers/23775718 | PubMed |
| 10 | 7519174 | Effect of substance P on superoxide anion and IL-8 production by human PMNL. | Immunology | 1994 | https://conductscience.org/library/papers/7519174 | PubMed |
| 11 | 27539537 | Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches. | Br J Haematol | 2016 | https://conductscience.org/library/papers/27539537 | PubMed |
| 12 | 8556479 | Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. | Clin Diagn Lab Immunol | 1994 | https://conductscience.org/library/papers/8556479 | PubMed |
| 13 | 25569375 | Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. | Cytokine | 2015 | https://conductscience.org/library/papers/25569375 | PubMed |
| 14 | 15551290 | Cytokine profile of sickle cell disease in Oman. | Am J Hematol | 2004 | https://conductscience.org/library/papers/15551290 | PubMed |
| 15 | 20304807 | Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. | Blood | 2010 | https://conductscience.org/library/papers/20304807 | PubMed |
| 16 | 7678516 | In vitro stimulatory effect of substance P on hematopoiesis. | Blood | 1993 | https://conductscience.org/library/papers/7678516 | PubMed |
| 17 | 23874164 | Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. | PLoS Med | 2013 | https://conductscience.org/library/papers/23874164 | PubMed |
| 18 | 23115062 | Patients with sickle cell disease have increased sensitivity to cold and heat. | Am J Hematol | 2013 | https://conductscience.org/library/papers/23115062 | PubMed |
| 19 | 12510705 | Psychosocial burden of sickle cell disease on caregivers in a Nigerian setting. | J Natl Med Assoc | 2002 | https://conductscience.org/library/papers/12510705 | PubMed |
| 20 | 12614204 | Guidelines for the management of the acute painful crisis in sickle cell disease. | Br J Haematol | 2003 | https://conductscience.org/library/papers/12614204 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TAC1 | 6863 | PubTator's text mining | https://conductscience.org/library/genes/6863 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39398396
GET https://conductscience.org/api/papers/v1/39398396/references?page=2